B. T. Sridhar, G. Y. Nagesh, K. Prashantha, M. Yamuna, S. Sanjay, K. R. Srinath, K. Ranjinikanth, R. S. Gani, R. Nalini, S. M. Basavarajaiah
{"title":"发现作为新德里金属-β-内酰胺酶-1 潜在抑制剂的新型伊沙替丁包络噁二唑:合成、光谱分析、抗菌和分子建模研究","authors":"B. T. Sridhar, G. Y. Nagesh, K. Prashantha, M. Yamuna, S. Sanjay, K. R. Srinath, K. Ranjinikanth, R. S. Gani, R. Nalini, S. M. Basavarajaiah","doi":"10.1134/S106816202404023X","DOIUrl":null,"url":null,"abstract":"<p><b>Objective:</b> Efficient synthesis of isatin Schiff’s bases (<b>IIIa–IIId</b>) and isatin-derived 1,3,4-oxadizoles (<b>IVa–IVd</b>) and evaluation of their <i>in vitro</i> antibacterial, antifungal, and anti-TB activities. The molecular docking studies were performed with protein New Delhi Metallo-Beta-lactamase-1 and <i>Mycobacterium tuberculosis</i> enoyl reductase and molecular dynamics simulation. <b>Methods:</b> The chemical structures were confirmed by IR, NMR, and mass spectroscopic techniques. The biological screenings were studied for the foresaid compounds for their <i>in vitro</i> antibacterial, antifungal, and anti-TB activity using MIC method. Molecular docking and dynamics simulation studies were conducted using AutoDock software with proteins New Delhi Metallo-Beta-lactamase-1 (NDM-1, PDB ID: 3ZR9) and <i>Mycobacterium tuberculosis</i> enoyl reductase (INHA, PDB ID: 4TZK). <b>Results and Discussion:</b> The compounds (<b>IVa–IVc</b>) displayed excellent <i>in vitro</i> antimicrobial activity. Also, the compounds (<b>IVa–IVc</b>), were found to be most active with a MIC of 3.125 µg/mL. For the docked proteins, all the compounds exhibited a substantial binding affinity. Further, molecular dynamics were disclosed for compounds (<b>IVa–IVc</b>). <b>Conclusions:</b> The compounds (<b>IIIa–IIId</b>) and (<b>IVa–IVd</b>) were synthesized from substituted isatins, <i>p</i>-amino benzoic acid, and isoniazid with moderate to excellent yields. These reactions are simple, convenient, and hitherto novel. In docking studies the compounds (<b>IVa–IVc</b>) showed excellent bind affinity towards the enzymes.</p>","PeriodicalId":758,"journal":{"name":"Russian Journal of Bioorganic Chemistry","volume":"50 4","pages":"1376 - 1389"},"PeriodicalIF":1.1000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Discovery of Novel Isatin Encompassing Oxadiazoles as Potential Inhibitors against New Delhi Metallo-β-lactamase-1: Synthesis, Spectral Analysis, Antimicrobial, and Molecular Modeling Studies\",\"authors\":\"B. T. Sridhar, G. Y. Nagesh, K. Prashantha, M. Yamuna, S. Sanjay, K. R. Srinath, K. Ranjinikanth, R. S. Gani, R. Nalini, S. M. Basavarajaiah\",\"doi\":\"10.1134/S106816202404023X\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><b>Objective:</b> Efficient synthesis of isatin Schiff’s bases (<b>IIIa–IIId</b>) and isatin-derived 1,3,4-oxadizoles (<b>IVa–IVd</b>) and evaluation of their <i>in vitro</i> antibacterial, antifungal, and anti-TB activities. The molecular docking studies were performed with protein New Delhi Metallo-Beta-lactamase-1 and <i>Mycobacterium tuberculosis</i> enoyl reductase and molecular dynamics simulation. <b>Methods:</b> The chemical structures were confirmed by IR, NMR, and mass spectroscopic techniques. The biological screenings were studied for the foresaid compounds for their <i>in vitro</i> antibacterial, antifungal, and anti-TB activity using MIC method. Molecular docking and dynamics simulation studies were conducted using AutoDock software with proteins New Delhi Metallo-Beta-lactamase-1 (NDM-1, PDB ID: 3ZR9) and <i>Mycobacterium tuberculosis</i> enoyl reductase (INHA, PDB ID: 4TZK). <b>Results and Discussion:</b> The compounds (<b>IVa–IVc</b>) displayed excellent <i>in vitro</i> antimicrobial activity. Also, the compounds (<b>IVa–IVc</b>), were found to be most active with a MIC of 3.125 µg/mL. For the docked proteins, all the compounds exhibited a substantial binding affinity. Further, molecular dynamics were disclosed for compounds (<b>IVa–IVc</b>). <b>Conclusions:</b> The compounds (<b>IIIa–IIId</b>) and (<b>IVa–IVd</b>) were synthesized from substituted isatins, <i>p</i>-amino benzoic acid, and isoniazid with moderate to excellent yields. These reactions are simple, convenient, and hitherto novel. In docking studies the compounds (<b>IVa–IVc</b>) showed excellent bind affinity towards the enzymes.</p>\",\"PeriodicalId\":758,\"journal\":{\"name\":\"Russian Journal of Bioorganic Chemistry\",\"volume\":\"50 4\",\"pages\":\"1376 - 1389\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Russian Journal of Bioorganic Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://link.springer.com/article/10.1134/S106816202404023X\",\"RegionNum\":4,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Bioorganic Chemistry","FirstCategoryId":"92","ListUrlMain":"https://link.springer.com/article/10.1134/S106816202404023X","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
摘要目的:高效合成异靛基希夫碱(IIIa-IIId)和异靛基 1,3,4-噁二唑(IVA-IVd),并评估其体外抗菌、抗真菌和抗结核活性。与蛋白质新德里金属-β-内酰胺酶-1 和结核分枝杆菌烯酰还原酶进行了分子对接研究,并进行了分子动力学模拟。方法:通过红外光谱、核磁共振和质谱技术确认了化学结构。采用 MIC 法对上述化合物的体外抗菌、抗真菌和抗结核活性进行了生物筛选研究。使用 AutoDock 软件与蛋白质新德里金属-β-内酰胺酶-1(NDM-1,PDB ID:3ZR9)和结核分枝杆菌烯酰还原酶(INHA,PDB ID:4TZK)进行了分子对接和动力学模拟研究。结果与讨论:化合物(IVa-IVc)显示出优异的体外抗菌活性。此外,化合物(IVa-IVc)的活性最高,其 MIC 为 3.125 µg/mL。对于对接的蛋白质,所有化合物都表现出很强的结合亲和力。此外,还披露了化合物(IVA-IVc)的分子动力学。结论化合物 (IIIa-IIId) 和 (IVa-IVd) 是由取代的异汀类化合物、对氨基苯甲酸和异烟肼合成的,产量中等到极好。这些反应简单、方便,是迄今为止的新发现。在对接研究中,化合物(IVa-IVc)与酶的结合亲和力极佳。
Discovery of Novel Isatin Encompassing Oxadiazoles as Potential Inhibitors against New Delhi Metallo-β-lactamase-1: Synthesis, Spectral Analysis, Antimicrobial, and Molecular Modeling Studies
Objective: Efficient synthesis of isatin Schiff’s bases (IIIa–IIId) and isatin-derived 1,3,4-oxadizoles (IVa–IVd) and evaluation of their in vitro antibacterial, antifungal, and anti-TB activities. The molecular docking studies were performed with protein New Delhi Metallo-Beta-lactamase-1 and Mycobacterium tuberculosis enoyl reductase and molecular dynamics simulation. Methods: The chemical structures were confirmed by IR, NMR, and mass spectroscopic techniques. The biological screenings were studied for the foresaid compounds for their in vitro antibacterial, antifungal, and anti-TB activity using MIC method. Molecular docking and dynamics simulation studies were conducted using AutoDock software with proteins New Delhi Metallo-Beta-lactamase-1 (NDM-1, PDB ID: 3ZR9) and Mycobacterium tuberculosis enoyl reductase (INHA, PDB ID: 4TZK). Results and Discussion: The compounds (IVa–IVc) displayed excellent in vitro antimicrobial activity. Also, the compounds (IVa–IVc), were found to be most active with a MIC of 3.125 µg/mL. For the docked proteins, all the compounds exhibited a substantial binding affinity. Further, molecular dynamics were disclosed for compounds (IVa–IVc). Conclusions: The compounds (IIIa–IIId) and (IVa–IVd) were synthesized from substituted isatins, p-amino benzoic acid, and isoniazid with moderate to excellent yields. These reactions are simple, convenient, and hitherto novel. In docking studies the compounds (IVa–IVc) showed excellent bind affinity towards the enzymes.
期刊介绍:
Russian Journal of Bioorganic Chemistry publishes reviews and original experimental and theoretical studies on the structure, function, structure–activity relationships, and synthesis of biopolymers, such as proteins, nucleic acids, polysaccharides, mixed biopolymers, and their complexes, and low-molecular-weight biologically active compounds (peptides, sugars, lipids, antibiotics, etc.). The journal also covers selected aspects of neuro- and immunochemistry, biotechnology, and ecology.